Global Peripheral Vascular Devices Market Industry: Market Size & Forecast 2026

Peripheral vascular devices are used in interventional procedures to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis, and other vascular disorders affecting the limbs and peripheral circulation. The market includes atherectomy devices, angioplasty balloons, peripheral stents, embolization devices, thrombectomy systems, and inferior vena cava filters. North America currently leads in revenue share, supported by high procedure volumes, established reimbursement pathways, and advanced hospital infrastructure.

• •Estimated global market value of $10.14 billion in 2025, with a 6.1% CAGR.
• •Devices span diagnostic catheters, therapeutic stents, balloons, and plaque-removal systems.
• •North America holds the largest regional share due to high PAD prevalence and procedure adoption.

The increasing global burden of peripheral artery disease and other vascular conditions is the primary force behind market expansion, alongside a growing geriatric population that is more susceptible to atherosclerosis. Improvements in imaging guidance and device miniaturization have made minimally invasive endovascular interventions the preferred treatment route, expanding the eligible patient pool. Rising healthcare expenditure in emerging economies and improved screening programs are also accelerating procedure volumes worldwide.

• •Rising prevalence of diabetes, obesity, and smoking-related PAD expands the addressable patient base.
• •Aging populations in developed and emerging markets increase demand for vascular interventions.
• •Shift from open surgery to minimally invasive endovascular procedures broadens device utilization.

By type, peripheral stents and angioplasty balloons represent the largest revenue segments, while atherectomy and thrombectomy devices are the fastest-growing categories due to expanding clinical indications. Hospitals account for the majority of end-user demand, with ambulatory surgical centers gaining share as outpatient vascular interventions become more common. Regionally, North America leads, followed by Europe, while Asia-Pacific is projected to record the fastest growth through 2031.

• •Stents and angioplasty balloons dominate by revenue; atherectomy and thrombectomy devices are growing fastest.
• •Hospitals remain the leading end-user segment, with ambulatory surgical centers expanding rapidly.
• •Asia-Pacific is the fastest-growing region, driven by healthcare investment and rising procedure volumes.

What are the recent trends and outlook?

The market outlook through the early 2030s is positive, with sustained mid-single-digit growth supported by demographic trends and clinical adoption. Drug-coated balloons and next-generation drug-eluting stents continue to gain clinical acceptance, while AI-enabled imaging and robotic-assisted catheter navigation are emerging as differentiators. Expansion into emerging markets and the development of bioresorbable scaffold technologies are expected to shape the next phase of competitive intensity.

• •Drug-coated balloons and bioabsorbable stents are advancing as preferred treatment options.
• •AI-driven imaging and robotic-assisted interventions are emerging technology frontiers.
• •Emerging-market expansion and outpatient migration are expected to sustain long-term growth.